Xavier Legras

1.0k total citations
14 papers, 726 citations indexed

About

Xavier Legras is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Xavier Legras has authored 14 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Epidemiology and 5 papers in Immunology. Recurrent topics in Xavier Legras's work include CRISPR and Genetic Engineering (5 papers), Immunotherapy and Immune Responses (4 papers) and Hepatitis B Virus Studies (4 papers). Xavier Legras is often cited by papers focused on CRISPR and Genetic Engineering (5 papers), Immunotherapy and Immune Responses (4 papers) and Hepatitis B Virus Studies (4 papers). Xavier Legras collaborates with scholars based in United States, Poland and China. Xavier Legras's co-authors include Helen Y. Wang, Xiaojun Xia, Jiabing Ji, Shu Zheng, Liang Zhu, Jun Ki Hong, Rong‐Fu Wang, Jun Cui, Pingping Shen and Zhijian J. Chen and has published in prestigious journals such as Cell, Nature Communications and Gastroenterology.

In The Last Decade

Xavier Legras

14 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Legras United States 11 404 317 129 103 99 14 726
Ian Gaël Rodrigue‐Gervais Canada 11 571 1.4× 356 1.1× 199 1.5× 104 1.0× 69 0.7× 13 880
Daniel Seidel Germany 8 238 0.6× 344 1.1× 94 0.7× 83 0.8× 134 1.4× 8 659
Yanlin Zhao China 16 419 1.0× 189 0.6× 306 2.4× 178 1.7× 103 1.0× 45 986
Bennett O. V. Shum Australia 8 536 1.3× 617 1.9× 200 1.6× 70 0.7× 51 0.5× 13 1.1k
Ana‐Maria Dragoi United States 13 392 1.0× 422 1.3× 91 0.7× 92 0.9× 76 0.8× 25 934
Chin‐Wen Lai United States 10 291 0.7× 183 0.6× 95 0.7× 162 1.6× 181 1.8× 13 727
Nanfang Peng China 15 296 0.7× 281 0.9× 205 1.6× 65 0.6× 56 0.6× 15 651
Cheol‐Hee Yoon South Korea 14 386 1.0× 227 0.7× 94 0.7× 130 1.3× 53 0.5× 34 699
Helen Lee United States 10 258 0.6× 167 0.5× 99 0.8× 82 0.8× 40 0.4× 16 622
Zhijun Su China 17 310 0.8× 280 0.9× 267 2.1× 125 1.2× 59 0.6× 47 822

Countries citing papers authored by Xavier Legras

Since Specialization
Citations

This map shows the geographic impact of Xavier Legras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Legras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Legras more than expected).

Fields of papers citing papers by Xavier Legras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Legras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Legras. The network helps show where Xavier Legras may publish in the future.

Co-authorship network of co-authors of Xavier Legras

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Legras. A scholar is included among the top collaborators of Xavier Legras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Legras. Xavier Legras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Chen, Tong, Mercedes Barzi, Hyunjae R. Kim, et al.. (2025). CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type I. JHEP Reports. 7(4). 101327–101327. 1 indexed citations
2.
Kruse, Robert L., Mercedes Barzi, Xavier Legras, et al.. (2021). A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome. JHEP Reports. 3(2). 100252–100252. 5 indexed citations
3.
Bissig-Choisat, Beatrice, Michele Alves‐Bezerra, Barry Zorman, et al.. (2021). A human liver chimeric mouse model for non-alcoholic fatty liver disease. JHEP Reports. 3(3). 100281–100281. 35 indexed citations
4.
Kruse, Robert L., Xavier Legras, & Mercedes Barzi. (2020). Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection. Virus Research. 292. 198224–198224. 8 indexed citations
5.
Barzi, Mercedes, Kang Ho Kim, Xavier Legras, et al.. (2018). Rapid Disruption of Genes Specifically in Livers of Mice Using Multiplex CRISPR/Cas9 Editing. Gastroenterology. 155(6). 1967–1970.e6. 16 indexed citations
6.
Kruse, Robert L., Thomas Shum, Haruko Tashiro, et al.. (2018). HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice. Cytotherapy. 20(5). 697–705. 65 indexed citations
7.
Barzi, Mercedes, Barry Zorman, Xing Liu, et al.. (2017). A novel humanized mouse lacking murine P450 oxidoreductase for studying human drug metabolism. Nature Communications. 8(1). 39–39. 27 indexed citations
8.
Tsao, Christopher, et al.. (2017). Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells. PLoS ONE. 12(5). e0177824–e0177824. 17 indexed citations
9.
Kruse, Robert L., Thomas Shum, Xavier Legras, et al.. (2017). In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy. Molecular Therapy — Methods & Clinical Development. 7. 32–41. 14 indexed citations
10.
Barzi, Mercedes, Xavier Legras, Leroy Hubert, et al.. (2016). Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia. Nature Communications. 7(1). 12642–12642. 100 indexed citations
11.
Bissig-Choisat, Beatrice, Lili Wang, Xavier Legras, et al.. (2015). Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model. Nature Communications. 6(1). 7339–7339. 45 indexed citations
12.
Matsueda, Satoko, Mingjun Wang, Jinsheng Weng, et al.. (2012). Identification of Prostate-Specific G-Protein Coupled Receptor as a Tumor Antigen Recognized by CD8+ T Cells for Cancer Immunotherapy. PLoS ONE. 7(9). e45756–e45756. 13 indexed citations
13.
Cui, Jun, Liang Zhu, Xiaojun Xia, et al.. (2010). NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways. Cell. 141(3). 483–496. 361 indexed citations
14.
Trzyna, Wendy, Xavier Legras, & John S. Cordingley. (2006). A type-1 metacaspase from Acanthamoeba castellanii. Microbiological Research. 163(4). 414–423. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ian Gaël Rodrigue‐Gervais Breakdown of academic impact, for papers by Daniel Seidel Breakdown of academic impact, for papers by Yanlin Zhao Breakdown of academic impact, for papers by Bennett O. V. Shum Breakdown of academic impact, for papers by Ana‐Maria Dragoi Breakdown of academic impact, for papers by Chin‐Wen Lai Breakdown of academic impact, for papers by Nanfang Peng Breakdown of academic impact, for papers by Cheol‐Hee Yoon Breakdown of academic impact, for papers by Helen Lee Breakdown of academic impact, for papers by Zhijun Su
Rankless by CCL
2026